Ironwood Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Ironwood Investment Counsel's BMY Position: Q2 2026 in Review
Ironwood Investment Counsel held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 4,500 shares worth $259K. The position accounts for 0.03% of the portfolio, ranked #243.
Ironwood Investment Counsel first reported a position in BMY in Q4 2014 and has held it in 18 quarters since. The position peaked at $409K in Q2 2016. 1,603 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Ironwood Investment Counsel held 4,500 shares of Bristol-Myers Squibb worth $259K as of Q2 2026.
- Ironwood Investment Counsel left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.03% of Ironwood Investment Counsel's portfolio in Q2 2026, its #243 holding.
- Ironwood Investment Counsel first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 18 quarters since.
- Ironwood Investment Counsel's Bristol-Myers Squibb position peaked at $409K in Q2 2016.
- 1,603 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Ironwood Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.